DISRUPTION OF DOMINANT B-CELL/PLASMA CELL CLONES IN RHEUMATOID ARTHRITIS SYNOVIUM BY RITUXIMAB CORRELATES WITH TREATMENT RESPONSE

被引:0
|
作者
Doorenspleet, M. E. [1 ]
Klarenbeek, P. L. [1 ,2 ]
Boumans, M. J. [1 ]
Thurlings, R. M. [1 ]
Esveldt, R. E. [1 ]
van Schaik, B. D.
van Kampen, A. H.
Gerlag, D. M. [1 ]
Baas, F. [3 ]
Tak, P. P. [1 ]
Plenge, R. M. [2 ]
de Vries, N. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[3] Univ Amsterdam, Acad Med Ctr, Genome Anal Lab, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1136/annrheumdis-2012-eular.2467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:313 / 313
页数:1
相关论文
共 50 条
  • [31] B cells, be gone - B-cell depletion in the treatment of rheumatoid arthritis
    Tsokos, GC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25): : 2546 - 2548
  • [32] The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
    Cambridge, G.
    Perry, H. C.
    Nogueira, L.
    Serre, G.
    Parsons, H. M.
    De La Torre, I.
    Dickson, M. C.
    Leandro, M. J.
    Edwards, J. C. W.
    [J]. JOURNAL OF AUTOIMMUNITY, 2014, 50 : 67 - 76
  • [33] B-Cell Activating Factor Levels in Rheumatoid Arthritis Patients in Response to Treatment with Biologics
    Pyrpasopoulou, Athina
    Balaska, Ekaterini
    Triantafyllou, Areti
    Anyfanti, Panagiota
    Aslanidis, Spyros
    Douma, Stella
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2012, 32 (07): : 338 - 340
  • [34] Interleukin-7: a potential factor supporting B-cell maturation in the rheumatoid arthritis synovium
    Ponchel, F.
    Churchman, S. M.
    El-Jawhari, J. J.
    Burska, A. N.
    Chambers, P.
    Vital, E. M.
    El-Sherbiny, Y. M.
    Jones, E.
    Conaghan, P. G.
    Goeb, V
    Emery, P.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) : 253 - 262
  • [35] B Cell Activation Biomarkers as Predictive Factors for the Response to Rituximab in Rheumatoid Arthritis
    Sellam, Jeremie
    Hendel-Chavez, Houria
    Rouanet, Stephanie
    Abbed, Karim
    Combe, Bernard
    Le Loet, Xavier
    Tebib, Jacques
    Sibilia, Jean
    Taoufik, Yassine
    Dougados, Maxime
    Mariette, Xavier
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 933 - 938
  • [36] STATINS DO NOT INFLUENCE CLINICAL RESPONSE AND B CELL DEPLETION AFTER RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Das, S.
    Matilla, M. Fernandez
    Dass, S.
    Vital, E.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 196 - 196
  • [37] ANTI-DESTRUCTIVE EFFECT OF RITUXIMAB AND B-CELL COUNT IN RHEUMATOID ARTHRITIS PATIENTS
    Pivanova, Anastasia V.
    Lukina, Galina V.
    Sigidin, Yakov A.
    Smirnov, Aleksandr V.
    Kuzikyants, Kristina Kh
    Kuznetsova, Anna Yu
    Nasonov, Evgeni L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A97 - A97
  • [38] B-CELLS AND B-CELL CLONES IN RHEUMATOID SYNOVITIS
    NATVIG, JB
    RANDEN, I
    THOMPSON, KM
    WAALEN, K
    FORRE, O
    STEINITZ, M
    TAUSSIG, M
    BEALE, D
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (04) : 499 - 499
  • [39] Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis
    Das, Sudipto
    Matilla, Meritxell Fernandez
    Dass, Shouvik
    Buch, Maya H.
    Rawstron, Andrew C.
    Vital, Edward M.
    Emery, Paul
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (03) : 463 - 464
  • [40] Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis
    Tak, Paul P.
    Doorenspleet, Marieke E.
    de Hair, Maria J. H.
    Klarenbeek, Paul L.
    van Beers-Tas, Marian H.
    van Kampen, Antoine H. C.
    van Schaardenburg, Dirkjan
    Gerlag, Danielle M.
    Baas, Frank
    de Vries, Niek
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (11) : 1924 - 1930